Search research articles
Contact Us
Filters
Showing results (51-60 of 94) with videos related to
Page
of 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1988
Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial
R L Miller, R M Bukowski, G T Budd, et al.
Journal of Biological Response Modifiers
|
December 1, 1990
Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effects
R M Bukowski, S Murthy, J Sergi, et al.
Cancer
|
February 15, 1992
A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma
R M Bukowski, G Inoshita, P Yalavarthi, et al.
American Journal of Surgery
|
August 1, 1985
Vein valve transplantation
S A Taheri, D R Pendergast, E Lazar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Phase I study of WR-2721 and carboplatin
G T Budd, R Ganapathi, L Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1997
Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial
C A Russell, S J Green, J O'Sullivan, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
December 1, 1991
Phase I trial of continuous infusion interleukin-2 and doxorubicin in patients with refractory malignancies
R M Bukowski, J S Sergi, G T Budd, et al.
Brain Research
|
May 10, 1988
Isolation and characterisation of glutamate receptor antagonists from venoms of orb-web spiders
T Budd, P Clinton, A Dell, et al.
Cancer Research
|
November 15, 1989
Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects
G T Budd, B Osgood, B Barna, et al.
Cancer
|
September 26, 1997
Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumors
G T Budd, R Ganapathi, D J Adelstein, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 94) with videos related to
Sort By:
Page
of 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1988
Clinical modulation of doxorubicin resistance by the calmodulin-inhibitor, trifluoperazine: a phase I/II trial
R L Miller, R M Bukowski, G T Budd, et al.
Journal of Biological Response Modifiers
|
December 1, 1990
Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effects
R M Bukowski, S Murthy, J Sergi, et al.
Cancer
|
February 15, 1992
A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma
R M Bukowski, G Inoshita, P Yalavarthi, et al.
American Journal of Surgery
|
August 1, 1985
Vein valve transplantation
S A Taheri, D R Pendergast, E Lazar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Phase I study of WR-2721 and carboplatin
G T Budd, R Ganapathi, L Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1997
Megestrol acetate and aminoglutethimide/hydrocortisone in sequence or in combination as second-line endocrine therapy of estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group phase III trial
C A Russell, S J Green, J O'Sullivan, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
December 1, 1991
Phase I trial of continuous infusion interleukin-2 and doxorubicin in patients with refractory malignancies
R M Bukowski, J S Sergi, G T Budd, et al.
Brain Research
|
May 10, 1988
Isolation and characterisation of glutamate receptor antagonists from venoms of orb-web spiders
T Budd, P Clinton, A Dell, et al.
Cancer Research
|
November 15, 1989
Phase I clinical trial of interleukin 2 and alpha-interferon: toxicity and immunologic effects
G T Budd, B Osgood, B Barna, et al.
Cancer
|
September 26, 1997
Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumors
G T Budd, R Ganapathi, D J Adelstein, et al.
Page
of 10